title: Glybera's second act: the curtain rises on the high cost of therapy.
authors: Seppo
authors: S
authors: Ylä-Herttuala
mesh_terms: D016527:Drug Costs; D015316:Genetic Therapy / Q000191:economics*; D017048:Health Care Costs; D006801:Humans
references: Nat Biotechnol. 2014 Dec;32(12):1192-3
references: 25489833
references: Mol Ther. 2012 Oct;20(10):1831-2
references: 23023051
references: Nat Biotechnol. 2014 Sep;32(9):874-6
references: 25203033